Aberrant crypt foci of the colon as precursors of adenoma and cancer

New England Journal of Medicine

Volumn 339, Issue 18, 1998, Pages 1277-1284

  Takayama, Tetsuji ^a   Katsuki, Shinichi ^a   Takahashi, Yasuo ^a   Ohi, Motoh ^a   Nojiri, Shuichi ^b   Sakamaki, Sumio ^a   Kato, Junji ^a   Kogawa, Katsuhisa ^a   Miyake, Hirotsugu ^a   Niitsu, Yoshiro ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b Shinnittetsu Muroran General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PREVENTION; CELL COUNT; CELL SIZE; CHEMOPROPHYLAXIS; COLON ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; CRYPT CELL; DYSPLASIA; ENDOSCOPY; FEMALE; GENE MUTATION; HEART DISEASE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ADENOMA; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COLON; COLONIC NEOPLASMS; COLONOSCOPY; FEMALE; GENES, RAS; HEART DISEASES; HUMANS; MALE; METHYLENE BLUE; MIDDLE AGED; OSTEOARTHRITIS; POINT MUTATION; PRECANCEROUS CONDITIONS; PREVALENCE; PROSPECTIVE STUDIES; SULINDAC;

EID: 17144464406     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199810293391803     Document Type: Article

References (34)

1. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987;37:147-51.
2. McLellan EA, Medline A, Bird RP. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneo-plastic lesions. Cancer Res 1991;51:5270-4.
3. Sutherland LA, Bird RP. The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon. Cancer Lett 1994;76:101-7.
4. Takahashi M, Minamoto T, Yamashita N, Kato T, Yazawa K, Esumi H. Eftect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Lett 1994;83:177-84.
5. Mereto E, Frencia L, Ghia M. Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. Cancer Lett 1994;76:5-9.
6. Stopera SA, Davie JR, Bird RP. Colonic aberrant crypt foci are associated with increased expression of c-fos. the possible role of modified c-fos expression in preneoplastic lesions in colon cancer. Carcinogenesis 1992;13:573-8.
7. Pretlow TP, Brasitus TA, Fulton NC, Chcyer C, Kaplan EL. K-ras mutations in putative preneoplastic lesions in human colon. J Natl Cancer Inst 1993;85:2004-7.
8. Vivona AA, Shpitz B, Medline A, et al. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis 1993;14:1777-81.
9. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation in aberrant crypt foci of colon: is there preference among K-ras mutants for malignant progression? Cancer 1995;75: Suppl:1527-33.
10. Shivapurkar N, Tang Z, Ferreira A, Nasim S, Garett C, Alabaster O. Sequential analysis of K-ras mutations in aberrant crypt foci and colonie tumors induced by azoxymethane in Fischer-344 rats on high-risk diet. Carcinogenesis 1994;15:775-8.
11. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 1995;108:434-40.
12. Pretlow TP. Aberrant crypt foci and K-ras mutations: earliest recognized players or innocent bystanders in colon carcinogenesis? Gastroenterology 1995;108:600-3.
13. Tachino N, Hayashi R, Liew C, Bailey G, Dashwood R. Evidence for ras gene mutation in 2-amino-3-methylimidazo[4,5-f]quinoline-induced colonie aberrant crypts in the rat. Mol Carcinog 1995;12:187-92.
14. Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 1991;22:287-94.
15. Roncucci L, Medline A, Bruce WR. Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev 1991;1:57-60.
16. Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 1991;51:1564-7
17. Pretlow TP, O'Riordan MA, Pretlow TG, Stellato TA. Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J Cell Biochem Suppl 1992;16G:55-62.
18. Roncucci L. Early events in human colorectal carcinogenesis: aberrant crypts and microadenoma. Ital J Gastroenterol 1992;24:498-501.
19. Di Gregorio C, Losi L, Fante R, et al. Histology of aberrant crypt foci in the human colon. Histopathology 1997;30:328-34. [Erratum, Histopathology 1997;31:491.]
20. Levi S, Urbano-Ispizua A, Gill R, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-502.
21. Cox DR. The analysis of binary data. London: Chapman & Hall, 1970.
22. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1991.
23. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston: Little, Brown, 1991.
24. Jen J, Powell SM, Papadopoulos N, et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994;54:5523-6.
25. Helwig EB. Benign tumors of the large intestine - incidence and distribution. Surg Gynecol Obstet 1943;76:419-26.
26. Bernstein MA, Feczko PJ, Halpert RD, Simms SM, Ackerman LV. Distribution of colonic polyps: increased incidence of proximal lesions in older patients. Radiology 1985;155:35-8.
27. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994;145:148-56.
28. Liu B, Nicolaides NC, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995;9:48-55.
29. Heath CW Jr. Rheumatoid arthritis, aspirin, and gastrointestinal cancer. J Nad Cancer Inst 1993;85:258-9.
30. Kune GA, Kunc S, Watson LF. Colorectal cancer risk, chronic illness, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988;48:4399-404.
31. Thun MJ, Namboodiri MN, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
32. Labayle D, Fischer D, Vielh P, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101:635-9.
33. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6.
34. Ladenheim J, Garcia G, Titzer D, et al. Effect of sulindac on sporadic colonic polyps. Gastroenterology 1995;108:1083-7.